Cognitive assessments
Cognitive assessments is an intervention with 12 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
4
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Predicting Cognitive Decline From Androgen Deprivation Therapy
Social COgnition Screening
Study to Understand Novel Biomarkers in Researching Dementia
Relevant Outcome Measures for Creatine Transporter Deficiency Patient
Electroencephalographic Study of the Mechanisms of Inhibition of Emotional Memories in Young Healthy Subjects
Clinical Trials (12)
Predicting Cognitive Decline From Androgen Deprivation Therapy
Social COgnition Screening
Study to Understand Novel Biomarkers in Researching Dementia
Relevant Outcome Measures for Creatine Transporter Deficiency Patient
Electroencephalographic Study of the Mechanisms of Inhibition of Emotional Memories in Young Healthy Subjects
Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Cognition and NeuroImaging in neuroDegenerative Disorders (CogNID)
Relationship and Central Mechanism Between Diabetes and Cognitive Impairment Based on Simultaneous EEG-fMRI Approach and Peripheral Neuropathology Biomarkers Assay
Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive Impairment
Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)
All 12 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 12